Circulating levels of tight junction proteins in multiple sclerosis: Association with inflammation and disease activity before and after disease modifying therapy

Serum Short-Chain Fatty Acids and Associations With Inflammation in Newly Diagnosed Patients With Multiple Sclerosis and Healthy Controls

(2021) Anna Olsson et al.   Frontiers in Immunology

Blood neurofilament light levels segregate treatment effects in multiple sclerosis

(2020) Bénédicte Delcoigne et al.   NEUROLOGY

Structure, Function, and Regulation of the Blood-Brain Barrier Tight Junction in Central Nervous System Disorders

(2020) Jeffrey J. Lochhead et al.   Frontiers in Physiology

Intestinal Barrier Breakdown and Mucosal Microbiota Disturbance in Neuromyelitis Optical Spectrum Disorders

(2020) Chunping Cui et al.   Frontiers in Immunology

Blood neurofilament light chain as a biomarker of MS disease activity and treatment response

(2019) Jens Kuhle et al.   NEUROLOGY

Loss of gut barrier integrity triggers activation of islet-reactive T cells and autoimmune diabetes

(2019) Chiara Sorini et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IFN-γ drives inflammatory bowel disease pathogenesis through VE-cadherin–directed vascular barrier disruption

(2019) Victoria Langer et al.   JOURNAL OF CLINICAL INVESTIGATION

The Prognostic Value of Endotoxemia and Intestinal Barrier Biomarker ZO-1 in Bacteremic Sepsis

(2019) Stelios F. Assimakopoulos et al.   AMERICAN JOURNAL OF THE MEDICAL SCIENCES

The intestinal barrier in multiple sclerosis: implications for pathophysiology and therapeutics

(2018) Carlos R Camara-Lemarroy et al.   BRAIN

Cytokine signaling in multiple sclerosis: Lost in translation

(2018) Kerstin Göbel et al.   Multiple Sclerosis Journal

Cytokine signaling in multiple sclerosis: Lost in translation

(2018) Kerstin Göbel et al.   Multiple Sclerosis Journal

Fingolimod reduces circulating tight-junction protein levels and in vitro peripheral blood mononuclear cells migration in multiple sclerosis patients

(2018) Pasquale Annunziata et al.   Scientific Reports

Short-chain fatty acids and gut microbiota in multiple sclerosis

(2018) Pernille Melbye et al.   ACTA NEUROLOGICA SCANDINAVICA

IFN-γ, IL-17A, or zonulin rapidly increase the permeability of the blood-brain and small intestinal epithelial barriers: Relevance for neuro-inflammatory diseases

(2018) Mohammed T. Rahman et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Serum Calprotectin: A Novel Diagnostic and Prognostic Marker in Inflammatory Bowel Diseases

(2016) Rahul Kalla et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Altered intestinal permeability in patients with relapsing–remitting multiple sclerosis: A pilot study

(2016) Maria Chiara Buscarinu et al.   Multiple Sclerosis Journal

Lipopolysaccharide Binding Protein and Oxidative Stress in a Multiple Sclerosis Model

(2016) Begoña M. Escribano et al.   Neurotherapeutics

Tight junctions in inflammatory bowel diseases and inflammatory bowel disease associated colorectal cancer

(2016) Jonathan Landy et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Altered intestinal permeability in patients with relapsing–remitting multiple sclerosis: A pilot study

(2016) Maria Chiara Buscarinu et al.   Multiple Sclerosis Journal

Role of the innate and adaptive immune responses in the course of multiple sclerosis

(2015) Bernhard Hemmer et al.   LANCET NEUROLOGY

Low sensitivity to glucocorticoid inhibition of in vitro Th17-related cytokine production in multiple sclerosis patients is related to elevated plasma lipopolysaccharide levels

(2013) Bruna Teixeira et al.   CLINICAL IMMUNOLOGY

Serum tight-junction proteins predict hemorrhagic transformation in ischemic stroke patients

(2012) R. Kazmierski et al.   NEUROLOGY

Tobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis

(2009) A. K. Hedstrom et al.   NEUROLOGY

Multiple sclerosis

(2008) Alastair Compston et al.   LANCET